Unfolded protein response:: its role in physiology and physiopathology

被引:36
作者
Foufelle, Fabienne [1 ]
Ferre, Pascal [1 ]
机构
[1] Univ Paris 06, Inserm U671, UMR S671, Ctr Biomed Cordeliers, F-75270 Paris 06, France
来源
M S-MEDECINE SCIENCES | 2007年 / 23卷 / 03期
关键词
D O I
10.1051/medsci/2007233291
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The endoplasmic reticulum (ER) is the first compartment in the secretary pathway. In the ER, proteins fold into their native configuration and are modified by post-translational modifications. Perturbations that alter ER homeostasis therefore disrupt folding and lead to the accumulation of unfolded proteins. These perturbations include modifications of Ca2+ homeostasis, increased demand for protein folding due to elevated synthesis of proteins in specialized cells or expression of a mutant misfolded protein. To limit accumulation of unfolded proteins, the cells have developed a specialized pathway: the unfolded protein response (UPR). UPR involves the activation of three transmembrane proteins of the ER: the PKR-like ER protein kinase (PERK), the activating transcription factor 6 (ATF6) and the inositol requiring enzyme 1 (IRE-1). The activation of all three components of the UPR depends on the dissociation of the luminal chaperone BiP/GRP78 from the luminal part of these proteins. Once activated, these pathways down-regulate protein synthesis through the phosphorylation of eiF2 (eucaryotic translation initiation factor 2) and up-regulate the transcription of genes which encode ER chaperones, protein folding enzymes and components of the ER-associated degradation system (ERAD). Growing evidences indicate that UPR signaling plays critical roles in nutrient sensing, differentiation of secretary cells such as pancreatic beta cell and antibody producing plasma cells, glucose homeostasis and in the development of pathologies linked to accumulation of aggregated proteins.
引用
收藏
页码:291 / 296
页数:6
相关论文
共 26 条
[1]   Impact of endoplasmic reticulum stress pathway on pancreatic β-cells and diabetes mellitus [J].
Araki, E ;
Oyadomari, S ;
Mori, M .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 228 (10) :1213-1217
[2]   A selective inhibitor-of eIF2α dephosphorylation protects cells from ER stress [J].
Boyce, M ;
Bryant, KF ;
Jousse, C ;
Long, K ;
Harding, HP ;
Scheuner, D ;
Kaufman, RJ ;
Ma, DW ;
Coen, DM ;
Ron, D ;
Yuan, JY .
SCIENCE, 2005, 307 (5711) :935-939
[3]   EIF2AK3, encoding translation initiation factor 2-α kinase 3, is mutated in patients with Wolcott-Rallison syndrome [J].
Delépine, M ;
Nicolino, M ;
Barrett, T ;
Golamaully, M ;
Lathrop, GM ;
Julier, C .
NATURE GENETICS, 2000, 25 (04) :406-409
[4]   Quality control in the endoplasmic reticulum [J].
Ellgaard, L ;
Helenius, A .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (03) :181-191
[5]   The stress of the endoplasmic reticulum: adaptation and toxicity [J].
Garlatti, M ;
Barouki, R .
M S-MEDECINE SCIENCES, 2002, 18 (05) :585-594
[6]   Diabetes mellitus and exocrine pancreatic dysfunction in Perk-/- mice reveals a role for translational control in secretory cell survival [J].
Harding, HP ;
Zeng, HQ ;
Zhang, YH ;
Jungries, R ;
Chung, P ;
Plesken, H ;
Sabatini, DD ;
Ron, D .
MOLECULAR CELL, 2001, 7 (06) :1153-1163
[7]   Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase [J].
Harding, HP ;
Zhang, YH ;
Ron, D .
NATURE, 1999, 397 (6716) :271-274
[8]   Regulated translation initiation controls stress-induced gene expression in mammalian cells [J].
Harding, HP ;
Novoa, I ;
Zhang, YH ;
Zeng, HQ ;
Wek, R ;
Schapira, M ;
Ron, D .
MOLECULAR CELL, 2000, 6 (05) :1099-1108
[9]   A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome) [J].
Inoue, H ;
Tanizawa, Y ;
Wasson, J ;
Behn, P ;
Kalidas, K ;
Bernal-Mizrachi, E ;
Mueckler, M ;
Marshall, H ;
Donis-Keller, H ;
Crock, P ;
Rogers, D ;
Mikuni, M ;
Kumashiro, H ;
Higashi, K ;
Sobue, G ;
Oka, Y ;
Permutt, MA .
NATURE GENETICS, 1998, 20 (02) :143-148
[10]   Induction of neuronal death by ER stress in Alzheimer's disease [J].
Katayama, T ;
Imaizumi, K ;
Manabe, T ;
Hitomi, J ;
Kudo, T ;
Tohyama, M .
JOURNAL OF CHEMICAL NEUROANATOMY, 2004, 28 (1-2) :67-78